Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-bromo-1H-indazol-1-yl)-6,7-dimethoxycinnoline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

947694-53-3

Post Buying Request

947694-53-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

947694-53-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 947694-53-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,6,9 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 947694-53:
(8*9)+(7*4)+(6*7)+(5*6)+(4*9)+(3*4)+(2*5)+(1*3)=233
233 % 10 = 3
So 947694-53-3 is a valid CAS Registry Number.

947694-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-bromoindazol-1-yl)-6,7-dimethoxycinnoline

1.2 Other means of identification

Product number -
Other names 4-(4-bromo-1-indazolyl)-6,7-dimethoxycinnoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:947694-53-3 SDS

947694-53-3Downstream Products

947694-53-3Relevant academic research and scientific papers

CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS

-

Page/Page column 57; 69, (2010/11/28)

The present invention is directed to certain cinnoline compounds of formula (I) that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and process for preparing such compounds. The invention is also directed to methods of treating diseases treatable by modulation of PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 947694-53-3